Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

447 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
Bukholm IK, Nesland JM, Børresen-Dale AL. Bukholm IK, et al. J Pathol. 2000 Jan;190(1):15-9. doi: 10.1002/(SICI)1096-9896(200001)190:1<15::AID-PATH489>3.0.CO;2-L. J Pathol. 2000. PMID: 10640987
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Laake K, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):175-80. Genes Chromosomes Cancer. 1997. PMID: 9071570
TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.
Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R. Skomedal H, et al. J Pathol. 1997 Feb;181(2):158-65. doi: 10.1002/(SICI)1096-9896(199702)181:2<158::AID-PATH742>3.0.CO;2-8. J Pathol. 1997. PMID: 9120719
Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.
Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA. Aas T, et al. Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960. Acta Oncol. 1996. PMID: 9142957
Screening for ESR mutations in breast and ovarian cancer patients.
Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL. Anderson TI, et al. Hum Mutat. 1997;9(6):531-6. doi: 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4. Hum Mutat. 1997. PMID: 9195227
Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.
Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Int J Cancer. 1997 Sep 26;73(1):38-41. doi: 10.1002/(sici)1097-0215(19970926)73:1<38::aid-ijc7>;2-2. Int J Cancer. 1997. PMID: 9334807
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer.
Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD. Kraggerud SM, et al. Pathol Res Pract. 1997;193(7):471-8. doi: 10.1016/s0344-0338(97)80099-4. Pathol Res Pract. 1997. PMID: 9342752
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors.
Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL, Gaudernack G. Breivik J, et al. Int J Cancer. 1997 Dec 19;74(6):664-9. doi: 10.1002/(sici)1097-0215(19971219)74:6<664::aid-ijc18>;2-5. Int J Cancer. 1997. PMID: 9421366
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.
Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Virchows Arch. 1997 Nov;431(5):317-21. doi: 10.1007/s004280050105. Virchows Arch. 1997. PMID: 9463572
A rare CYP19 (aromatase) variant may increase the risk of breast cancer.
Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. Kristensen VN, et al. Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006. Pharmacogenetics. 1998. PMID: 9511180
447 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page